Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
BPLA Biotechnology Committee Double Patenting: Not as Simple as a Terminal Disclaimer
Tell a Friend About This EventTell a Friend
 

3/28/2017
When: March 28, 2017
11:30 am
Where: WilmerHale
60 State Street
Boston, Massachusetts  02109
United States
Contact: BPLA Biotechnology Committee


Online registration is closed.
« Go to Upcoming Event List  

 

 

Biotechnology Committee Luncheon & Seminar

 Double Patenting: 
Not as Simple as a Terminal Disclaimer

 

In recent years, the Federal Circuit has led a paradigm shift in the law of double patenting, starting with the decision in Gilead v. Natco and continuing with AbbVie v. Kennedy.  These decisions have placed new limits on existing patents and future applications alike, potentially cutting into the terms of valuable patent estates in ways that were not anticipated when the patents and applications were originally filed.  Patent practitioners, portfolio and licensing managers, and litigators all need to be aware of the evolving legal contours and their implications for prosecuting, licensing, and enforcing effective patent portfolios.  In addition to covering the seminal cases, we will also review the legal landscape post-Gilead, as well as application of double patenting by the U.S. Patent and Trademark Office (USPTO).  Among other topics, we will consider:

  • prosecution and claiming strategies to avoid double patenting rejections at the USPTO;
  • application filing strategies to maximize portfolio value while avoiding or minimizing double patenting risks;
  • reassessing the value and patent term of existing and future license agreements;
  • the role of double patenting in assessing freedom to operate; and
  • using double patenting as an additional avenue to challenge patents in litigation and how to insulate against such challenges. 

Speakers:


Jeffrey Jacobstein, Finnegan


Matthew Van Eman, MD, McCarter & English

 

 

 

Tuesday, March 28, 2017
 11:30 pm - 1:00 PM

 

 

CLE:

We are applying for 1.0 hours of CLE credit in New York
which many other states accept through reciprocity.

Cost including CLE credit:

Members $30 / Non-Members $50

For financial aid, please contact rebecca.mcneill@mcneillbaur.com

 

 

 

60 State Street

Boston MA 02109

 

  

BPLA Biotechnology Committee Co Chairs
Rebecca McNeill, McNeill Baur
Bo Han, WilmerHale
 biotechnology@bpla.org

 

Boston Patent Law Association
One Batterymarch Park, Suite 101
Quincy, MA 02169
Phone: 617.507.5570

Membership Software Powered by YourMembership  ::  Legal